Literature DB >> 20468886

The use and protection of rifampin as an anti-tuberculosis agent.

O Clarke.   

Abstract

At present rifampin is mainly indicated for resistant cases of pulmonary tuberculosis, although it may become a first choice drug. Care must be taken in prescription and management. This article lists indications, dosages and lengths of rifampin therapy, together with appropriate combination drugs.

Entities:  

Year:  1973        PMID: 20468886      PMCID: PMC2370848     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  2 in total

Review 1.  Tuberculosis--chemotherapy.

Authors:  K M Citron
Journal:  Br Med J       Date:  1972-02-12

2.  Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.

Authors:  C W Jeanes; A G Jessamine; L Eidus
Journal:  Can Med Assoc J       Date:  1972-04-22       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.